Literature DB >> 20392751

A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin.

C A Dorrian1, B J Toole, S Alvarez-Madrazo, A Kelly, J M C Connell, A M Wallace.   

Abstract

BACKGROUND: Primary aldosteronism (PA), the most common secondary cause of hypertension, can be screened for using the aldosterone/renin ratio. This ratio is raised in PA and its accuracy depends on the ability to measure plasma renin at extremely low concentrations.
METHODS: We compared two different procedures for assessing plasma renin. The conventional method, which measures plasma renin activity (PRA), is technically demanding and laborious, and the Diasorin Liaison method, which measures plasma renin concentration (PRC), is an automated immunoassay. Results from each method were used to calculate the aldosterone/renin ratio (ARR) and the performance of the Diasorin Liaison method compared with that of the conventional assay using receiver operator characteristic curves.
RESULTS: The analytical and functional sensitivity of the PRC method were 2.1 and 5 microIU/mL, respectively. Intra- and inter-assay precision were <7.2% and 10.4%, respectively. There was significant (9%) prorenin interference. Samples with PRA > 1.0 ng/mL/h showed significant correlation with PRC (r = 0.93; P < 0.05; n = 146); however, with PRA < 1.0 ng/mL/h, no significant correlation occurred (r = 0.14; P < 0.05; n = 79). An aldosterone (pmol/L)/PRC(microIU/mL) ratio of >35, in patients with aldosterone >300 pmol/L, resulted in 100% sensitivity and 93% specificity, when compared with the commonly accepted aldosterone (pmol/L)/PRA (ng/mL/h) ratio of >750, in identifying patients who may suffer from PA.
CONCLUSION: This study indicates the feasibility of using the automated PRC assay as a replacement for the conventional manual PRA assay in calculating the ARR as a first-line screen for PA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392751     DOI: 10.1258/acb.2010.009230

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  11 in total

Review 1.  Issues in the Diagnosis and Treatment of Primary Aldosteronism.

Authors:  Jacopo Burrello; Silvia Monticone; Fabrizio Buffolo; Martina Tetti; Giuseppe Giraudo; Domenica Schiavone; Franco Veglio; Paolo Mulatero
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-09

Review 2.  Adrenal Diagnostics: An Endocrinologist's Perspective focused on Hyperaldosteronism.

Authors:  Peter J Fuller
Journal:  Clin Biochem Rev       Date:  2013-11

3.  Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.

Authors:  Ryo Morimoto; Yoshikiyo Ono; Yuta Tezuka; Masataka Kudo; Sachiko Yamamoto; Toshiaki Arai; Celso E Gomez-Sanchez; Hironobu Sasano; Sadayoshi Ito; Fumitoshi Satoh
Journal:  Hypertension       Date:  2017-06-26       Impact factor: 10.190

4.  Diagnosis of primary aldosteronism in the hypertension specialist centers in Italy: a national survey.

Authors:  Giacomo Pucci; Silvia Monticone; Claudia Agabiti Rosei; Giulia Balbi; Fabio Bertacchini; Fabio Ragazzo; Francesca Saladini; Martino F Pengo
Journal:  J Hum Hypertens       Date:  2018-08-06       Impact factor: 3.012

5.  Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension.

Authors:  Alexander G Camenzind; Jessica Grace van der Gugten; Robert Popp; Daniel T Holmes; Christoph H Borchers
Journal:  Clin Proteomics       Date:  2013-12-20       Impact factor: 3.988

6.  Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: A meta-analysis.

Authors:  Xiyue Li; Richa Goswami; Shumin Yang; Qifu Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-08-17       Impact factor: 1.636

7.  Age-Related Cutoffs of Plasma Aldosterone/Renin Concentration for Primary Aldosteronism Screening.

Authors:  Linqiang Ma; Ying Song; Mei Mei; Wenwen He; Jinbo Hu; Qingfeng Cheng; Ziwei Tang; Ting Luo; Yue Wang; Qianna Zhen; Zhihong Wang; Hua Qing; Yihong He; Qifu Li; Shumin Yang
Journal:  Int J Endocrinol       Date:  2018-07-16       Impact factor: 3.257

8.  Adrenocortical hypofunction with simultaneous primary aldosteronism: A case report.

Authors:  Kaiyong Liang; Xiaojuan Ou; Xukai Huang; Qunfang Lan
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

9.  Feasibility of Screening Primary Aldosteronism by Aldosterone-to-Direct Renin Concentration Ratio Derived from Chemiluminescent Immunoassay Measurement: Diagnostic Accuracy and Cutoff Value.

Authors:  Tianqi Li; Yeshuo Ma; Ying Zhang; Yue Liu; Tingting Fu; Ri Zhang; Kai Kang; Yingchao Yang; Lixin Wang; Yinong Jiang; Yan Lu
Journal:  Int J Hypertens       Date:  2019-07-02       Impact factor: 2.420

Review 10.  New advances in the diagnosis of primary aldosteronism.

Authors:  Hang Shen; Zhi-Xin Xu; Qi-Fu Li
Journal:  Chronic Dis Transl Med       Date:  2020-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.